MARCKS and breast cancer: To address the possibility that persistent elevation of phospho-MARCKS predispose breast cancer cells to the treatment of paclitaxel, there are two possible mechanisms by which elevated phospho-MARCKS attenuates the anti-cancer efficacy of paclitaxel.